AAAAAA
Results: 1-25/33
Authors:
WELL M
NABER KG
KINZIGSCHIPPERS M
SORGEL F
Citation: M. Well et al., URINARY BACTERICIDAL ACTIVITY AND PHARMACOKINETICS OF ENOXACIN VERSUSNORFLOXACIN AND CIPROFLOXACIN IN HEALTHY-VOLUNTEERS AFTER A SINGLE ORAL DOSE, International journal of antimicrobial agents, 10(1), 1998, pp. 31-38
Authors:
NABER KG
HOFSTETTER A
Citation: Kg. Naber et A. Hofstetter, RECOMMENDED STANDARDS IN THE DIAGNOSIS AND THERAPY OF URINARY-TRACT INFECTIONS, European urology, 34(1), 1998, pp. 1-6
Authors:
NABER KG
THEURETZBACHER U
KINZIG M
SAVOV O
SORGEL F
Citation: Kg. Naber et al., URINARY-EXCRETION AND BACTERICIDAL ACTIVITIES OF A SINGLE ORAL DOSE OF 400 MILLIGRAMS OF FLEROXACIN VERSUS A SINGLE ORAL DOSE OF 800 MILLIGRAMS OF PEFLOXACIN IN HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1659-1665
Authors:
NABER KG
WELL M
KINZIGSCHIPPERS M
SORGEL F
Citation: Kg. Naber et al., URINARY BACTERICIDAL ACTIVITY AND CONCENTRATIONS OF ENOXACIN VERSUS NORFLOXACIN AND CIPROFLOXACIN IN HEALTHY-VOLUNTEERS AFTER A SINGLE ORALDOSE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4411-4411
Authors:
NABER KG
WELL M
HOLLAUER K
KIRCHBAUER D
WITTE W
Citation: Kg. Naber et al., IN-VITRO ACTIVITY OF ENOXACIN VERSUS CIPROFLOXACIN, FLEROXACIN, LOMEFLOXACIN, OFLOXACIN, PEFLOXACIN, AND RUFLOXACIN AGAINST UROPATHOGENS, Chemotherapy, 44(2), 1998, pp. 77-84
Authors:
HOFSTETTER A
BRUHL P
NABER KG
WEIDNER W
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
LUDWIG G
RUBBEN H
SCHABEL J
STOCKAMP K
Citation: A. Hofstetter et al., DIAGNOSIS OF INFECTIONS OF THE UROGENITALTRACT, Der Urologe, 36(5), 1997, pp. 487-489
Authors:
HOFSTETTER A
WEIDNER W
BRUHL P
NABER KG
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
LUDWIG G
RUBBEN H
SCHABEL J
STOCKAMP K
Citation: A. Hofstetter et al., INFECTIONS OF ANDROLOGICAL SIGNIFICANCE, Der Urologe, 36(5), 1997, pp. 496-499
Authors:
HOFBAUER H
NABER KG
KINZIGSCHIPPERS M
SORGEL F
RUSTIGEWIEDEMANN C
WIEDEMANN B
REIZ A
KRESKEN M
Citation: H. Hofbauer et al., URINE BACTERICIDAL ACTIVITY OF PEFLOXACIN VERSUS NORFLOXACIN IN HEALTHY FEMALE VOLUNTEERS AFTER A SINGLE 800-MG ORAL DOSE, Infection, 25(2), 1997, pp. 121-126
Authors:
FRANKENSCHMIDT A
NABER KG
BISCHOFF W
KULLMANN K
Citation: A. Frankenschmidt et al., ONCE-DAILY FLEROXACIN VERSUS TWICE-DAILY CIPROFLOXACIN IN TREATMENT OF COMPLICATED URINARY-TRACT INFECTIONS, The Journal of urology, 158(4), 1997, pp. 1494-1499
Authors:
MELEKOS MD
ASBACH HW
GERHARZ E
ZARAKOVITIS IE
WEINGAERTNER K
NABER KG
Citation: Md. Melekos et al., POST-INTERCOURSE VERSUS DAILY CIPROFLOXACIN PROPHYLAXIS FOR RECURRENTURINARY-TRACT INFECTIONS IN PREMENOPAUSAL WOMEN, The Journal of urology, 157(3), 1997, pp. 935-939
Authors:
NABER KG
Citation: Kg. Naber, CLINICAL EFFICACY OF PEFLOXACIN IN COMPLICATED URINARY-TRACT INFECTIONS, UNCOMPLICATED GONOCOCCAL URETHRITIS, PROSTATITIS AND EPIDIDYMITIS - AN OVERVIEW, Clinical drug investigation, 11, 1996, pp. 15-24
Authors:
JEWESSON PG
NABER KG
DUPONT HL
NORRBY SR
DELLAMONICA P
Citation: Pg. Jewesson et al., THE ROLE OF PEFLOXACIN IN COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED INFECTIONS - QUESTIONS AND ANSWERS, Clinical drug investigation, 11, 1996, pp. 43-47
Authors:
NABER KG
Citation: Kg. Naber, OPTIMAL MANAGEMENT OF UNCOMPLICATED AND COMPLICATED URINARY-TRACT INFECTIONS, Medical microbiology letters, 5(7), 1996, pp. 372-380
Authors:
NABER KG
DISILVERIO F
GEDDES A
GUIBERT J
Citation: Kg. Naber et al., COMPARATIVE EFFICACY OF SPARFLOXACIN VERSUS CIPROFLOXACIN IN THE TREATMENT OF COMPLICATED URINARY-TRACT INFECTION, Journal of antimicrobial chemotherapy, 37, 1996, pp. 135-144
Authors:
NABER KG
WITTE W
BAUERNFEIND A
Citation: Kg. Naber et al., THERAPY OF COMPLICATED URINARY-TRACT INFE CTIONS, Nieren- und Hochdruckkrankheiten, 25(11), 1996, pp. 567-571
Authors:
NABER KG
Citation: Kg. Naber, FLUOROQUINOLONES IN URINARY-TRACT INFECTIONS - PROPER AND IMPROPER USE, Drugs, 52, 1996, pp. 27-33
Authors:
DURACK DT
MUKHTAR AH
NABER KG
PERCIVAL A
KRCMERY V
VANDENBROEK PJ
ABULABAN M
DAVEY PG
STILLE W
SCHAAD UB
KUNGU C
Citation: Dt. Durack et al., DISCUSSION - SECTION 2, Drugs, 52, 1996, pp. 37-41
Authors:
NABER KG
Citation: Kg. Naber, FLEROXACIN OVERVIEW, Chemotherapy, 42, 1996, pp. 1-9
Authors:
JAEHDE U
SORGEL F
NABER KG
ZURCHER J
SCHUNACK W
Citation: U. Jaehde et al., DISTRIBUTION KINETICS OF ENOXACIN AND ITS METABOLITE OXOENOXACIN IN EXCRETORY FLUIDS OF HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 2092-2097
Authors:
JAEHDE U
SORGEL F
REITER A
SIGL G
NABER KG
SCHUNACK W
Citation: U. Jaehde et al., EFFECT OF PROBENECID ON THE DISTRIBUTION AND ELIMINATION OF CIPROFLOXACIN IN HUMANS, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 532-541
Authors:
NABER KG
Citation: Kg. Naber, URINARY-TRACT INFECTION IN MEN, INCLUDING PROSTATITIS, EPIDIDYMITIS, NONSPECIFIC URETHRITIS AND REITERS-SYNDROME, Current opinion in infectious diseases, 7(1), 1994, pp. 9-19
Authors:
NABER KG
BAURECHT W
FISCHER M
KRESKEN M
Citation: Kg. Naber et al., PEFLOXACIN SINGLE-DOSE IN THE TREATMENT OF ACUTE UNCOMPLICATED LOWER URINARY-TRACT INFECTIONS IN WOMEN - A METAANALYSIS OF 7 CLINICAL-TRIALS, International journal of antimicrobial agents, 4(3), 1994, pp. 197-202
Authors:
NABER KG
Citation: Kg. Naber, UNCOMPLICATED URINARY-TRACT INFECTIONS - IS SINGLE-DOSE THERAPY EFFECTIVE, International journal of antimicrobial agents, 4, 1994, pp. 190000039-190000045
Authors:
NABER KG
WITTE W
BAUERNFEIND A
WIEDEMANN B
WAGENLEHNER F
KLARE I
HEISIG P
Citation: Kg. Naber et al., CLINICAL-SIGNIFICANCE AND SPREAD OF FLUOROQUINOLONE RESISTANT UROPATHOGENS IN HOSPITALIZED UROLOGICAL PATIENTS, Infection, 22, 1994, pp. 190000122-190000127
Authors:
JODAL U
HELWIG H
WINBERG J
BAILEY RR",YOSHITEDA,"NEU HC
NABER KG
MATSUMOTO T",NAIDE,TRABANT
Citation: U. Jodal et al., INTERNATIONAL CONSENSUS DISCUSSION ON CLINICAL-EVALUATION OF DRUG EFFICACY IN URINARY-TRACT INFECTION - GENERAL DISCUSSION, Infection, 22, 1994, pp. 190000016-190000018